Skip to main content
. 2020 Nov 19;2020:8819771. doi: 10.1155/2020/8819771

Figure 3.

Figure 3

miR-204 improved cardiac function in DOX-treated mice. (a) Body weight and heart weight in each group (n = 9‐12). (b) The ratio of the heart weight (HW)/tibia length (TL) and lung weight (LW)/TL (n = 9‐12). (c) Left ventricular end-diastolic diameter (LVEDd) and ejection fraction (EF) of mice in each group (n = 9‐12). (d) Hemodynamic analysis of mice in the indicated groups (n = 8‐11). (e) The levels of serum biochemical parameters (CK-MB, LDH, and cTnI) in each group (n = 6). P < 0.05 versus NS+GFP and #P < 0.05 versus DOX+GFP.